ad

Wockhardt Ltd. (WOCKPHARMA) Share Price Rises 2.11% Today to Rs 2,233.30

29 Sept 2026 • 9:35 am

Wockhardt Ltd. (WOCKPHARMA) Share Price Rises 2.11% Today to Rs 2,233.30
Wockhardt Ltd. (WOCKPHARMA) share price rose to Rs 2,233.3 today, up 2.11% from the previous close. Market cap was Rs 36,827.23 crore.

Wockhardt Ltd. Share Price rose today to Rs 2,233.30, up 2.11% from the previous close of Rs 2,187.20, with market capitalisation at Rs 36,827.23 crore. The move places Wockhardt among the notable gainers in Healthcare and in the Pharmaceuticals & Drugs industry for the session. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Wockhardt Ltd. Share Price Today, the most relevant facts are the day’s open, high, low and turnover, because those numbers show how the stock behaved through the session. The stock started above the previous close, moved higher during the day and finished near the upper portion of its range. That makes the move meaningful as a price action event, even though the dataset does not assign a reason behind it.

Wockhardt Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 2,233.3
Previous Close Rs 2,187.2
Today's Move Rs 46.1 (+2.11%)
Open Rs 2,201.05
High Rs 2,255
Low Rs 2,196.85
Turnover Rs 1.67 crore
Market Capitalisation Rs 36,827.23 crore
Market Cap Category Large Cap

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,233.3 from the previous close of Rs 2,187.2, a move of Rs 46.1 or 2.11%. The stock opened at Rs 2,201.05, reached a high of Rs 2,255, recorded a low of Rs 2,196.85.

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,233.3 from the previous close of Rs 2,187.2, a move of Rs 46.1 or 2.11%. The stock opened at Rs 2,201.05, moved to an intraday high of Rs 2,255 and a low of Rs 2,196.85. That combination shows a session where buyers were able to keep the price above the prior close throughout the day and push it to a higher range before the close.

Wockhardt Ltd. Share Price Today also shows a fairly contained range compared with the day’s gain. From the open at Rs 2,201.05 to the high at Rs 2,255, the stock had room to extend after the opening print. The low of Rs 2,196.85 remained close to the open and well above the previous close, which suggests that the stock did not lose its upward bias during the session. The close at Rs 2,233.30 sat closer to the upper part of the range than the lower end, which is useful when reading price action in isolation. In other words, the market respected the higher pricing level for most of the day.

Turnover stood at Rs 1.67 crore, which is the only value-based activity marker available in the dataset. That figure is enough to note that the session had recorded participation, but it does not support any claim about unusually heavy or light trading conditions. The key point for Wockhardt Ltd. Share Price is that the day’s price structure was constructive: open above the previous close, higher intraday high, and a positive finish. Since no catalyst is supplied, the article should be read as a factual market recap rather than a news-led explanation.

For event-specific interpretation, the important distinction is between movement and cause. The movement is clear: Wockhardt Ltd. Share Price added Rs 46.10 and climbed 2.11% on the day. The cause is not included in the source data, so it should not be inferred. That is why this section focuses on where the stock opened, where it traded, and where it finished. These details matter most when a share price rises without a stated trigger, because they show whether the move was sustained or simply a brief spike. In this case, the data supports a sustained positive session rather than a narrow intraday jump.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 36,827.23 crore
P/E Ratio 86.9x
P/B Ratio 7.06x
ROE 4.29%
ROCE 6.79%
EPS Rs 25.17
Book Value Per Share Rs 309.81
Dividend Yield 0%

Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 86.9x, P/B 7.06x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.

Wockhardt Ltd. has a market capitalisation of Rs 36827.23 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 86.9x, P/B at 7.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 86.9x
Benchmark Median P/E 32.59x
Benchmark Average P/E 49x
Benchmark P/E Range 3.46x to 707.31x
Company P/B Ratio 7.06x
Benchmark Median P/B 2.88x
Company ROE 4.29%
Benchmark Median ROE 11.7%
Company ROCE 6.79%
Benchmark Median ROCE 13.61%
Company Market Capitalisation Rs 36,827.23 crore
Benchmark Median Market Cap Rs 783.26 crore

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 86.9x, which is above the benchmark median of 32.59x, a difference of +166.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.7%, a difference of -63.33%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.61%, a difference of -50.11%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,44,716.74 36.5 5.1 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,55,115.31 86.51 14.33 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,89,613.38 84.92 20.64 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,19,899.96 26.79 4.48 19.69 21.39
Cipla Ltd. CIPLA 1,12,875.68 33.29 3.19 11.83 16

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 86.9x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 36,827.23 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Wockhardt

  • Wockhardt Ltd. Share Price rose 2.11% today to Rs 2,233.30.
  • Market capitalisation stands at Rs 36,827.23 crore.
  • P/E of 86.9x and P/B of 7.06x are above the industry medians supplied.
  • ROE of 4.29% and ROCE of 6.79% are below the industry medians supplied.
  • The stock sits in the Healthcare sector and Pharmaceuticals & Drugs industry.

About Wockhardt Ltd.

Wockhardt Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE as WOCKPHARMA, and the supplied market data places it among the more valuable listed names in its industry. The latest Wockhardt Ltd. Stock News around the share price rise is therefore being read in the context of a business that sits in a closely watched healthcare segment. Based on the supplied fields, the article can confirm its sector, industry, valuation and profitability metrics, while broader operating details are not expanded beyond what the dataset supports. For Univest readers, Wockhardt Ltd. Share Price and Wockhardt Ltd. Stock Analysis are best understood through this combination of company size, valuation and benchmark comparison.

Track Wockhardt Ltd. Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Use the Wockhardt Ltd. live share-price page, the Univest top gainers screener and Univest market blogs to review live stock data, top-gainers lists and related market analysis. These pages help readers follow how Wockhardt Ltd. Share Price behaves across sessions, while keeping the discussion grounded in verified market information.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did Wockhardt Ltd. Share Price rise today?

Ans. The supplied data confirms a 2.11% rise in Wockhardt Ltd. Share Price, but it does not identify a company-specific trigger. The session is explained only by the open, high, low, close and turnover figures provided.

What is Wockhardt Ltd. Share Price today?

Ans. Wockhardt Ltd. Share Price today is Rs 2,233.30. It closed Rs 46.10 above the previous close of Rs 2,187.20, which equals a 2.11% gain. The stock also traded between Rs 2,196.85 and Rs 2,255.

What is Wockhardt Ltd. market capitalisation?

Ans. Wockhardt Ltd. market capitalisation stands at Rs 36,827.23 crore. That is well above the same-industry median in the supplied benchmark set, placing the company among the larger names in the Healthcare sector.

How does Wockhardt compare on valuation and profitability?

Ans. Wockhardt trades at a P/E of 86.9x and P/B of 7.06x, both above the industry medians supplied. Its ROE of 4.29% and ROCE of 6.79% are below those benchmark medians, showing a premium valuation backdrop.

How does Wockhardt compare with selected pharma peers?

Ans. In the peer set shown, Wockhardt’s market capitalisation is smaller than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its valuation is relatively high, while profitability ratios are lower than the peers listed.

Does Wockhardt pay a dividend?

Ans. The supplied dividend yield for Wockhardt Ltd. is 0%. That means no dividend yield is shown in the dataset, so today’s discussion of Wockhardt Ltd. Share Price rests mainly on valuation, profitability and sector comparison.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down